Log In
BCIQ
Print this Print this
 

avibactam (NXL104)

Also known as: formerly AVE1330A

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionBeta lactamase (LACTB) inhibitor
Molecular Target Beta lactamase (LACTB)
Mechanism of ActionBeta lactamase inhibitor
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase II
Standard IndicationGram-negative bacterial infection
Indication DetailsTreat hospital acquired Gram-negative bacterial infection; Treat infections due to beta-lactamase producing Enterobacteriaceae species
Regulatory Designation
PartnerAllergan plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today